ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 129

Rheumatologists’ Approaches to Diagnosis and Treatment of Depression

Erica Heiman, Barton Wise and Richard L. Kravitz, Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: depression, mental health, physician data and rheumatologic practice

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Health Services Research Poster I: Diagnosis, Management and Treatment Strategies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Depression in patients with rheumatic disorders contributes to morbidity, mortality, and health care utilization. We set out to examine rheumatologists’ approaches to and perceptions of depression in everyday practice.

Methods:

A questionnaire was mailed to 470 practicing rheumatologists in California; 226 (55%of eligible respondents, after removing those returned to sender and who reported they were not in active clinical practice) were included in the final analyses. Respondents provided information on demographics, practice characteristics, attitudes towards mental health, and practices related to depression. Logistic regression models were constructed to assess the relationship of rheumatologists’ personal and practice characteristics with their usual depression-related practices (medication management, referral to primary care, and referral to psychiatry).

Results:

Among responding rheumatologists, 51% reported that at least half their patients suffered from depression, many of them untreated. Nearly all providers (99%) reported addressing mental health issues during at least some visits. When these issues were raised, it was usually the physician who initiated the discussion (69%); only 9% reported regular use of a formal screening tool. Rheumatologists were equally likely to prescribe antidepressants, refer to a psychiatrist, or return the patient to the primary care physician; about 60% reported applying each of the 3 strategies to at least half of their patients. In logistic regression models, greater number of visits per week and greater percentage of patients with fibromyalgia were associated with more prescription of antidepressants (p<.05).

Conclusion:

Our findings point towards a gap in care provision. Rheumatologists see a great need for mental health services but too often lack the skills and time to address mental health issues.


Disclosure: E. Heiman, None; B. Wise, None; R. L. Kravitz, Takeda Pharmaceuticals, Lundbeck LLC, 8.

To cite this abstract in AMA style:

Heiman E, Wise B, Kravitz RL. Rheumatologists’ Approaches to Diagnosis and Treatment of Depression [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/rheumatologists-approaches-to-diagnosis-and-treatment-of-depression/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatologists-approaches-to-diagnosis-and-treatment-of-depression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology